AlzeCure Pharma AB (”AlzeCure” or ”The Company”) (FN STO: ALZCUR), which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer’s disease and pain, announced today that it will participate in the Pareto Securities 17th Annual Healthcare Conference on September 2, where CEO Martin Jönsson will give a company presentation and answer questions about the latest developments and AlzeCure’s plans for the future.
Venue: Hotel At Six, Brunkebergstorg 6, Stockholm
Format: Presentation and 1×1 meetings
Presentation time: September 2, 2026, 17:05–17:25 CEST (room: Event Small)
The presentation will also be available afterwards on AlzeCure’s website: https://www.alzecurepharma.se/en/presentations-and-interviews/
For more information about the event, please visit Pareto’s website: https://paretosec.com/updates/events-and-conferences
